Full Service Pharmaceutical R&D
ABOUT Vici
Vici delivers end-to-end drug development solutions for small pharma. We provide formulation development, analytical method validation and testing, cGMP clinical supplies manufacturing, FDA regulatory services, and CMC R&D consulting services. We are experts in NCE molecule development, NDA 505(b)(2), and ANDA development programs. Our experienced formulation scientists and chemists solve problems through innovation, speed, and flexibility offering excellent value for companies needing better R&D outcomes. Vici operates a pharmaceutical R&D center of excellence in Maryland, USA.
OUR VALUES
CUSTOMER FOCUS
EXCELLENCE IN R&D
INNOVATIVE MINDSET
We focus on constantly evolving our business to best fit our customers needs and stay at the forefront of pharmaceutical research and development.
LEADERSHIP
ANISH DHANARAJAN, Ph.D.
CEO
Dr. Anish Dhanarajan has over 20 years of experience as a scientist and is a leader in the pharmaceutical industry. After completing his PhD in Biomedical/Chemical Engineering with a focus on drug delivery at the University of Minnesota, he started his pharmaceutical industry career as an industrial postdoc at Pfizer, Michigan, developing mathematical and experimental methodologies for scaling up pharmaceutical manufacturing processes. Subsequently, he worked as a formulation scientist developing complex, controlled-release dosage forms.
After gaining experience as a scientist and leader at various companies including Mallinckrodt, CorePharma, and GSK, Anish co-founded Vici Health Sciences. As the CEO of Vici Health Sciences, Anish successfully selected and developed NDA and ANDA drug products for licensing, resulting in the commercialization of multiple pharmaceutical products. Currently, he is focused on developing Vici as an R&D center of excellence committed to providing world class end-to-end drug development and manufacturing services to other startups and small pharma.
FRANCESCA MINALE, M.ENG.
President
Francesca Minale is a well-rounded, experienced pharmaceutical product development expert with a broad understanding of formulations, analytical chemistry, regulatory requirements, and cGMP concepts.
As a tireless manager and scientist, Francesca has developed and filed over 20 products, authored multiple patents, and been responsible for over a dozen successful INDs to initiate Phase I and Phase II clinical studies. Francesca co-founded Vici with Dr. Dhanarajan and has successfully managed day-to-day operations, regulatory filings, and quality assurance.
Francesca Minale holds a Master’s degree in Biomedical Engineering at Cornell University and has over 13 years’ experience at CorePharma, WES Pharma and at Vici. Francesca is passionate about affordable housing and is involved in a variety of non-profit initiatives related to affordable housing and homelessness in the Baltimore area. In her free time, Francesca enjoys redesigning and renovating homes in need of repair to improve communities and neighborhoods.
